Nancy Pelosi, former Speaker of the House of Representatives, often makes headlines for her stock trades.
Her husband, Paul Pelosi, a venture capitalist, is one of Washington's most active traders.
Stay ahead of the markets: subscribe to TheStreet's free daily newsletter
While she denies being involved in her husband's business decisions, her portfolio has seen some notable successes, including a profitable investment in Nvidia.
According to trading platform Autopilot, Pelosi's portfolio posted an impressive 54% gain in 2024, outperforming most hedge funds.
<blockquote class="twitter-tweet”>
BREAKING: Pelosi did it
It officially ends 2024 up 54% and beat out Inverse Cramer for the top portfolio on Autopilot.
Never doubt the queen of… pic.twitter.com/eT941WTdPs
– Nancy Pelosi Stock Tracker (@PelosiTracker_) <a target="_blank" href="https://twitter.com/PelosiTracker_/status/1874859312616759754?ref_src=twsrc%5Etfw”>January 2, 2025
On January 17, he disclosed some of his recent transactions in official documents just before Trump took office. One of the stocks he invested in rose more than 40% after the disclosure.
McNamee/Getty wins
What stocks is Nancy Pelosi buying?
Pelosi bought 50 call options (a bet that a stock will go up) for Tempus ai (TEM) on January 14, with an exercise price of $20 per share. Each options contract typically represents 100 shares of the underlying stock.
Related: A Popular Congressman Just Bought These tech stocks
The total commercial value was between $50,000 and $100,000.
Tempus ai shares rose more than 40% in the two days following the disclosure.
Pelosi's other investments included purchasing call options on Alphabet. (GOOGLE) amazon (AMZN) NVIDIA (NVDA) power generation company Vistra (VST) and the cybersecurity company Palo Alto Networks (PANW) .
Meanwhile, it sold some of its stakes in Nvidia and Apple on December 31, 2024.
What does Tempus ai do?
Tempus ai is a healthcare technology company founded in 2015. It is incorporating ai into diagnostics to enable doctors and researchers to make personalized decisions based on data.
“The ability to deploy ai in precision medicine at scale has only recently become possible,” the company said in a filing with the SEC.
Related: The Analyst Who Bet Right on 2024 Reveals Top ai Stock Picks for 2025
“Advances in cloud computing, imaging technologies, large language models and low-cost molecular profiling, along with the digitization of large amounts of healthcare data, have created a landscape that we believe will “It's finally ripe for ai.”
Tempus ai's recent rally could also be fueled by the launch of its ai-enabled personal health concierge app, Olivia. The app organizes patients' health data in one place and uses ai to offer actionable recommendations.
Tempus ai went public on June 14, 2024, with its initial public offering priced at $37 per share.
The company has not yet made a profit. It reported losses of $290 million and $214 million for 2022 and 2023, respectively.
On January 13, Tempus ai reported preliminary revenue for the fourth quarter and full year 2024.
The company expects FY24 revenue to reach $693 million, representing approximately 30% year-over-year growth.
This falls short of Wall Street analysts' expectations of $716.98 million and is slightly below the high end of the company's November projections.
Related: Analysts Reveal Tempus ai Stock Price Targets
The company's projected fourth-quarter revenue of $200 million is also below the consensus estimate of $206.07 million.
Loop Capital lowered Tempus ai's price target to $52 from $57 with a Buy rating following preliminary results, citing the company's prior announcement of below-consensus fourth-quarter revenue, thefly.com reported.
Loop adds that Tempus ai also did not provide formal profitability guidance, other than that it expects a sequential improvement in adjusted EBITDA in the fourth quarter.
Cathie Wood will also buy Tempus ai
Cathie Wood, director of Ark Investment Management, also bought shares of Tempus ai. He began investing in stocks after its June 24 initial public offering and recently made several large purchases.
This month, for example, his Ark funds bought 186,532 shares of Tempus ai on January 17, 378,883 on January 13, and 53,376 on January 3.
More stock market forecasts for 2025
- stocks face correction risk as Santa Rally fails to deliver results
- Veteran Trader Who Correctly Picked Palantir as a Top Stock on the 24th Reveals the Best Stock for the 25th
- Five quantum computing stocks investors are targeting in 2025
- Goldman Sachs picks top sectors to own in 2025
That chunk of stock is now worth about $31 million.
Tempus ai shares, now trading at $50.45, have lost about 38% from their high of $78 in November.
Related: Veteran Fund Manager Issues Dire S&P 500 Warning for 2025
<script async src="https://platform.twitter.com/widgets.js” charset=”utf-8″>
